Dr. Wright is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7651 Medical Dr
Hudson, FL 34667Phone+1 727-868-9208Fax+1 727-868-6420
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
- Duke University HospitalResidency, Internal Medicine, 1984 - 1986
- University of North Carolina HospitalsInternship, Internal Medicine, 1983 - 1984
- University of North Carolina at Chapel Hill School of MedicineClass of 1983
Certifications & Licensure
- FL State Medical License 1996 - 2025
- GA State Medical License 1999 - 2023
- SC State Medical License 2001 - 2004
- NC State Medical License 1984 - 2000
- VA State Medical License 1987 - 2000
- MD State Medical License 1988 - 1995
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2014
Clinical Trials
- Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index Start of enrollment: 2013 Apr 01
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 551 citationsAtezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.Peter Schmid, Sylvia Adams, Hope S Rugo, Andreas Schneeweiss, Carlos H Barrios
The New England Journal of Medicine. 2018-11-29 - 345 citationsPrimary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectabl...David Miles, Joseph Gligorov, Fabrice Andre, David Cameron, Andreas Schneeweiss
Annals of Oncology. 2021-07-01 - 29 citationsOVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with be...Melissa M Hardesty, Thomas C Krivak, Gail S Wright, Erika Hamilton, Evelyn L Fleming
Gynecologic Oncology. 2022-08-01
Professional Memberships
- Member
- Member
- Fellow
- Fellow
- International Association for the Study of Lung Cancer - IASLCMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: